Search results for "Practice guidelines as topic"

showing 10 items of 308 documents

Editor's Choice – Follow-up of Patients After Revascularisation for Peripheral Arterial Diseases: A Consensus Document From the European Society of C…

2019

International audience; Peripheral arterial diseases comprise different clinical presentations, from cerebrovascular disease down to lower extremity artery disease, from subclinical to disabling symptoms and events. According to clinical presentation, the patient's general condition, anatomical location and extension of lesions, revascularisation may be needed in addition to best medical treatment. The 2017 European Society of Cardiology guidelines in collaboration with the European Society for Vascular Surgery have addressed the indications for revascularisation. While most cases are amenable to either endovascular or surgical revascularisation, maintaining long-term patency is often chall…

Disease030204 cardiovascular system & hematology030230 surgeryPostoperative Complications0302 clinical medicineRestenosisRecurrenceSecondary Preventionfollow-upRandomized Controlled Trials as TopicUltrasonography Doppler Duplexmedicine.diagnostic_test3. Good healthEuropeSystematic reviewPractice Guidelines as TopicIN-STENT RESTENOSISCardiologyCardiology and Cardiovascular MedicineVascular Surgical ProceduresReoperationmedicine.medical_specialtyConsensusRevascularisationINFRAINGUINAL VEIN BYPASSMEDLINEPhysical examinationSTENOSIS03 medical and health sciencesrestenosisperipheral arterial diseaseInternal medicinemedicineHumansANGIOPLASTYVELOCITY CRITERIAbusiness.industryMagnetic resonance imagingNATURAL-HISTORYPerioperativeVascular surgery3126 Surgery anesthesiology intensive care radiologymedicine.diseaseDUPLEX ULTRASOUND SURVEILLANCEENDOVASCULAR TREATMENTRISK-FACTORSSurgery[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCAROTID-ARTERYbusiness
researchProduct

Pattern of drug use by advanced cancer patients followed at home

2001

The aim of this study was to document the drugs most commonly prescribed to control symptoms in advanced cancer patients being followed at home. We analyzed data for 128 patients admitted to a home palliative care program from January 1993 to January 1995. All patients were followed at home until death by a team consisting of doctors and nurses, and were given two or three medical examinations a week. The most frequently prescribed drugs were analgesics and drugs commonly used to prevent NSAID-induced gastric toxicity. Slow-release morphine was the analgesic used most often. Most patients received more than four drugs. Younger people received morphine more often than did older patients. Co…

DrugMalemedicine.medical_specialtyPalliative caremedia_common.quotation_subjectAnalgesicMEDLINEAuditDrug Prescriptions03 medical and health sciences0302 clinical medicine030502 gerontologyNeoplasmsmedicineHumans030212 general & internal medicinePractice Patterns Physicians'Survival analysismedia_commonAgedRetrospective StudiesMedical AuditTerminal CareEvidence-Based Medicinebusiness.industryMedicine (all)Retrospective cohort studyGeneral MedicineEvidence-based medicineHome Care ServicesSurvival AnalysisDrug UtilizationEmergency medicinePractice Guidelines as TopicFemaleDrug Monitoring0305 other medical sciencebusiness
researchProduct

EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European…

2016

AIMS: To determine whether the Joint European Societies guidelines on cardiovascular prevention are being followed in everyday clinical practice of secondary prevention and to describe the lifestyle, risk factor and therapeutic management of coronary patients across Europe. METHODS AND RESULTS: EUROASPIRE IV was a cross-sectional study undertaken at 78 centres from 24 European countries. Patients <80 years with coronary disease who had coronary artery bypass graft, percutaneous coronary intervention or an acute coronary syndrome were identified from hospital records and interviewed and examined ≥ 6 months later. A total of 16,426 medical records were reviewed and 7998 patients (24.4% female…

EUROASPIRE InvestigatorsMaleCardiac & Cardiovascular SystemsTime FactorsEpidemiologyCARDIOVASCULAR-DISEASE PREVENTIONCoronary DiseaseComorbidity030204 cardiovascular system & hematologyOverweightlaw.invention0302 clinical medicineRandomized controlled triallawRisk FactorsPrevalenceSecondary PreventionARTERY-DISEASE030212 general & internal medicineEUROASPIREguidelinesProspective StudiesPractice Patterns Physicians'Societies MedicalSecondary preventionGLUCOSE REGULATIONSmokingcardiovascular preventionRANDOMIZED CONTROLLED-TRIALMiddle AgedClinical PracticeEuropeTreatment OutcomePractice Guidelines as TopicCardiologyLDL Cholesterol LipoproteinsFemaleGuideline Adherencemedicine.symptomCardiology and Cardiovascular MedicineLife Sciences & BiomedicineAdultmedicine.medical_specialtyAdolescentCardiologyHEART-DISEASERisk Assessmentrehabilitation03 medical and health sciencesYoung AdultCardiovascular preventionSDG 3 - Good Health and Well-beingInternal medicinemedicineHumansRisk factorCARDIAC REHABILITATIONExerciseAgedScience & TechnologyTask forcebusiness.industryCardiovascular AgentsDietCross-Sectional StudiesMYOCARDIAL-INFARCTIONCLINICAL-PRACTICEHealth Care SurveysCardiovascular System & CardiologySmoking CessationSedentary BehaviorbusinessRisk Reduction BehaviorTASK-FORCEEuropean journal of preventive cardiology
researchProduct

Recommendations for a nomenclature system for reporting methylation aberrations in imprinted domains

2018

The analysis of DNA methylation has become routine in the pipeline for diagnosis of imprinting disorders, with many publications reporting aberrant methylation associated with imprinted differentially methylated regions (DMRs). However, comparisons between these studies are routinely hampered by the lack of consistency in reporting sites of methylation evaluated. To avoid confusion surrounding nomenclature, special care is needed to communicate results accurately, especially between scientists and other health care professionals. Within the European Network for Human Congenital Imprinting Disorders we have discussed these issues and designed a nomenclature for naming imprinted DMRs as well …

Epigenomics0301 basic medicineCancer ResearchADNMedizinBiologyBioinformaticsMethylationGenomic Imprinting03 medical and health sciences0302 clinical medicineTerminology as TopicHealth careJournal Articleimprinting disordersAnimalsHumansPoint of ViewMolecular BiologyNomenclaturePolymorphism GeneticAberrant methylationbusiness.industryImprintingDNAMethylationDNA Methylation3. Good health030104 developmental biologyDifferentially methylated regions030220 oncology & carcinogenesisPractice Guidelines as TopicDNA methylationnomenclatureHuman genomemethylationSpecial careMetilacióbusinessEpigenetics
researchProduct

Global Initiative for Asthma (GINA) Strategy 2021 - Executive summary and rationale for key changes

2021

Funder: Global Initiative for Asthma

ExacerbationRespiratory SystemINHALED CORTICOSTEROIDSCritical Care and Intensive Care MedicineAsthma managementSINGLE-INHALERDOUBLE-BLINDRisk Factorsimmune system diseasesAdrenal Cortex HormonesRELIEVER THERAPYFormoterol FumarateMedicine and Health SciencesImmunology and AllergyAnti-Asthmatic AgentsChild11 Medical and Health SciencesLung functionMILD PERSISTENT ASTHMAExecutive summaryBiologic therapiesCombined Modality TherapyLUNG-FUNCTIONChild PreschoolPractice Guidelines as TopicPerspectiveDisease ProgressionDrug Therapy Combinationmedicine.drugPulmonary and Respiratory MedicineAdultmedicine.medical_specialtyBUDESONIDE/FORMOTEROL MAINTENANCEAdolescentMild asthmaMEDLINEInhaled corticosteroidsCONTROLLED-TRIALSkills trainingGINA Strategy 2021: Executive SummaryBUDESONIDE-FORMOTEROLAdministration InhalationmedicineHumansasthma preventionIntensive care medicineSEVERE EXACERBATIONSAsthmaasthma diagnosisbusiness.industryPatient AcuityInfantasthmamedicine.diseaseAsthmarespiratory tract diseasesSelf Carewf_140Formoterolwf_100businessasthma management
researchProduct

SARS-CoV-2: Impact on, Risk Assessment and Countermeasures in German Eye Banks.

2020

Introduction Since the beginning of the COVID-19 pandemic there has been some debate regarding the risk of transmission through tissue transplantation and tissue banking processes. Aim of the study To analyze the changes that SARS-CoV-2 has caused regarding the harvesting of corneal donor tissue and eye bank activities in Germany. Methods A questionnaire was provided to 26 eye banks in Germany, consisting of questions about adaptations made in the screening of potential donors and the harvesting of corneal tissue following the pandemic spread of SARS-CoV-2. Results Eighteen eye banks actively reduced recruitment of donors and two banks ceased all activity. Additional diagnostic screening wa…

Face shieldmedicine.medical_specialtybusiness.product_categoryTissue and Organ ProcurementSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedizinEye BanksRisk AssessmentCorneal DiseasesCorneal Transplantation03 medical and health sciencesCellular and Molecular Neuroscience0302 clinical medicineCorneaGermanySurveys and QuestionnairesPandemicmedicineDisease Transmission InfectiousHumansIntensive care medicinebusiness.industrySARS-CoV-2COVID-19Eye bankSensory SystemsTissue DonorsTransplantationOphthalmologymedicine.anatomical_structureMedical CountermeasuresDonationPractice Guidelines as TopicQuarantine030221 ophthalmology & optometryTissue and Organ Harvestingsense organsRisk assessmentbusiness030217 neurology & neurosurgeryCurrent eye research
researchProduct

Thirty-five years later, the first assisted reproductive technology program opens in Cambodia

2015

GynecologyMedical educationmedicine.medical_specialtyTime FactorsAssisted reproductive technologyReproductive Techniques Assistedbusiness.industrymedicine.medical_treatmentObstetrics and GynecologyHealth Services AccessibilityFertilityReproductive MedicinePregnancyInfertilityPractice Guidelines as TopicHumansMedicineFemaleClinical CompetenceProgram DevelopmentCambodiabusinessDeveloping CountriesFertility and Sterility
researchProduct

Overcoming barriers to evidence-based patient blood management: a restricted review

2020

Abstract Background Blood transfusions are associated with a range of adverse patient outcomes, including coagulopathy, immunomodulation and haemolysis, which increase the risk of morbidity and mortality. Consideration of these risks and potential benefits are necessary when deciding to transfuse. Patient blood management (PBM) guidelines exist to assist in clinical decision-making, but they are underutilised. Exploration of barriers to the implementation and utilisation of the PBM guidelines is required. This study aimed to identify common barriers and implementation strategies used to implement PBM guidelines, with a comparison against current expert opinion. Methods A restricted review a…

Health Knowledge Attitudes PracticeEvidence-based practiceMEDLINEHealth Informatics030204 cardiovascular system & hematologyCochrane LibraryHealth informaticsImplementation StrategiesConsolidated Framework for Implementation ResearchHealth administration03 medical and health sciences0302 clinical medicineNursingExpert Recommendations for Implementing ChangePatient blood managementMedicineHumansBlood Transfusion030212 general & internal medicineImplementation Sciencelcsh:R5-920business.industryHealth PolicyPublic Health Environmental and Occupational HealthHealth services researchGeneral MedicineHaemolysisOrganizational CultureVDP::Medisinske Fag: 700::Helsefag: 800Practice Guidelines as TopicBarrier MappingImplementation researchSystematic ReviewGuideline Adherencebusinesslcsh:Medicine (General)
researchProduct

Cardiovascular risk in patients without known cardiovascular disease.

2014

Understanding the risks of atherosclerotic cardiovascular disease (CVD) allows for better patient education and management. Multiple risk models have been validated in large patient populations and provide insights into the risks associated with CVD. When assessing such risks, we suggest using a model that predicts myocardial infarction, cardiovascular death, and/or cerebrovascular events. In this review, we analyze several risk models and stratify the risks associated with CVD. We suggest that appropriate profiling of patients at-risk of CVD will lead to better physician recognition and treatment of modifiable risk factors, appropriate application of ATP III treatment for hyperlipidemia, a…

Health Knowledge Attitudes PracticeRisk FactorModels TheoreticalCoronary heart diseaseMyocardial infarctionPatient Education as TopicCardiovascular DiseasesRisk FactorsCardiovascular DiseasePractice Guidelines as TopicBorderline risk factorHumansC Reactive ProteinCardiovascular multiple risk factorHumanEuropean review for medical and pharmacological sciences
researchProduct

Urticaria in children and adolescents: An updated review of the pathogenesis and management

2018

The present survey represents the latest data on diagnosis and management of childhood urticaria. It has been observed that urticaria occurs less often in children than adults, with symptoms rarely lasting for over 6 weeks. Triggers or aggravating factors can be found only in 21%-55% of cases. Finding autoantibodies in children does not impact a disease prognosis, unlike in adult patients, where the presence of autoantibodies is associated with a more prolonged run of the disease, a more severe prognosis and more intensive treatment methods. The incidence of food allergy equals to 8%-10% of cases. The incidence of Helicobacter Pylori infection in children is lower than that in adults and co…

Helicobacter pylori infectionPediatricsmedicine.medical_specialtyAdolescentUrticariaImmunologyOmalizumabDiseaseDiagnosis DifferentialPathogenesis03 medical and health sciences0302 clinical medicineFood allergyAnti-Allergic AgentsmedicineHumansImmunology and Allergy030212 general & internal medicineAggravating FactorChildbusiness.industryIncidence (epidemiology)Prognosismedicine.disease030228 respiratory systemChronic DiseasePractice Guidelines as TopicPediatrics Perinatology and Child HealthEtiologybusinessmedicine.drugPediatric Allergy and Immunology
researchProduct